Publication details

Immunology follow-up after rituximab treatment in pediatric non Hodgkin lymfoma patients

Title in English Immunology follow-up after rituximab treatment
Authors

HLAVÁČKOVÁ Eva KŘENOVÁ Zdenka ŠTĚRBA Jaroslav LITZMAN Jiří

Year of publication 2018
Type Conference abstract
MU Faculty or unit

Faculty of Medicine

Citation
Description Rituximab treatment leads to absolute transitional CD19+ B lymphocytopenia. IgG decrease could be delayed after the B cell recovery in the periphery. Clinical and laboratory sights of antibody secondary deficiency should be regularly monitored.
Related projects: